Biogen Inc (NASDAQ:BIIB)

419.44
Delayed Data
As of Apr 17
 -9.21 / -2.15%
Today’s Change
275.39
Today|||52-Week Range
480.18
+23.56%
Year-to-Date
It's A Big Weekend For Biotech
Apr 17 / Benzinga
J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog
Apr 14 / Zacks.com
Biotech Investors Shouldn't Miss These Stocks This Earnings - Earnings ESP
Apr 17 / Zacks.com
Biotech: Making sense of the science
Apr 13 / FT.com
Will Intuitive Surgical (ISRG) Surprise Earnings in Q1? - Analyst Blog
Apr 17 / Zacks.com
Will Pharmaceutical Sales Drive J&J (JNJ) Earnings Again? - Analyst Blog
Apr 13 / Zacks.com
Can Illumina (ILMN) Keep the Earnings Streak Alive in Q1? - Analyst Blog
Apr 17 / Zacks.com
Biogen, SodaStream, TASER International, Napco Security Technologies and SuperCom hig...
Apr 13 / Zacks.com
VIVUS Responds to Teva's Filing for Qsymia Generics - Analyst Blog
Apr 16 / Zacks.com
Bull of the Day: Biogen (BIIB) - Bull of the Day
Apr 13 / Zacks.com
AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog
Apr 16 / Zacks.com
10 Largest Companies by Market Cap in Biotech
Apr 11 / MotleyFool.com
Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog
Apr 16 / Zacks.com
The 3 Best Stocks to Invest in Biotechnology
Apr 11 / MotleyFool.com
The Zacks Analyst Blog Highlights: Medicines Co., Tekmira, GW Pharmaceuticals, Biogen...
Apr 16 / Zacks.com
Stock Market News for April 09, 2015 - Market News
Apr 09 / Zacks.com
Synta Pharmaceuticals (SNTA) Catches Eye: Stock Jumps 10.7% - Tale of the Tape
Apr 16 / Zacks.com
Stock Market News for April 08, 2015 - Market News
Apr 08 / Zacks.com
Biogen Reports New Data from Acute Optic Neuritis Study - Analyst Blog
Apr 15 / Zacks.com
Biosimilar drugs: spot the difference
Apr 08 / FT.com
Bayer to Expand Copanlisib Program by Three New Studies - Analyst Blog
Apr 15 / Zacks.com
Why Smart Money Loves This Biotech Stock
Apr 05 / MotleyFool.com
Biotech Stock Roundup: Favorable Briefing Documents for MDCO's Kengreal, Alexion Soli...
Apr 15 / Zacks.com
The Safest Biotech Bet on the Market
Apr 04 / MotleyFool.com
GoPro, Avon and Intel Highlight Tuesday's After-Hours Movers
Apr 14 / Benzinga
The Truly Staggering Cost of Alzheimer's Disease
Apr 04 / MotleyFool.com
Biogen Reports New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neuro...
Apr 14 / Benzinga
Has the Biotech Bubble Already Popped?
Apr 04 / MotleyFool.com
Alnylam Reports Publication of New Data on Hemophilia Drug - Analyst Blog
Apr 14 / Zacks.com
Drugs companies unite to mine genetic data
Mar 25 / FT.com
Amgen, Inc., Gilead Sciences, Inc., Biogen Inc, Celgene Corporation: Is A Biotech Bub...
Apr 14 / Investing Channel
Dow tumbles 292 points as economy shows cracks
Mar 25 / CNNMoney.com
Trade-Ideas: Biogen (BIIB) Is Today's Post-Market Leader Stock
Apr 14 / TheStreet.com
Nike leaps on higher sales and future orders
Mar 20 / FT.com
Aeterna Zentaris to Advance Hormone Drug to Phase III Study - Analyst Blog
Apr 14 / Zacks.com
Biogen's Alzheimer's drug shows early promise
Mar 20 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account